Abbott's Volt PFA System Demonstrates Sustained Long-Term Benefits For AFib Patients
27/4 08:41
(RTTNews) - Abbott (ABT) announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months for patients receiving pulsed field ablation (PFA) therapy with the Volt PFA System for the treatment of atrial fibrillation (AFib)....